Skip to main content

Advertisement

SpringerLink
Log in

Prostate Artery Embolization as a New Treatment for Benign Prostate Hyperplasia: Contemporary Status in 2016

  • New Imaging Techniques (A Rastinehad and S Rais-Bahrami, Section Editors)
  • Published:
Current Urology Reports Aims and scope Submit manuscript

Abstract

The gold standard treatment for benign prostate hyperplasia (BPH) is transurethral resection of the prostate (TURP) or open prostatectomy (OP). Recently, there has been increased interest and research in less invasive alternative treatments with less morbidity including prostate artery embolization (PAE). Several studies have shown PAE to be an effective alternative to TURP to treat lower urinary tract symptoms (LUTS) associated with BPH with decreased morbidity. Specifically, PAE has been advantageous in selected patient populations such as those with prostates too large for TURP or unsuitable surgical candidates, showing a promising potential for the future care of patients with BPH. Further studies are being done to demonstrate the clinical applications and advantages of this therapy in reduction of LUTS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Wei JT, Calhoun E, Jacobsen SJ. Urologic diseases in America project: benign prostatic hyperplasia. J Urol. 2005;173(4):1256–61.

    Article  PubMed  Google Scholar 

  2. American Urological Association guideline—management of benign prostatic hyperplasia (BPH).

  3. Carnevale FC, Moreira AM, Antunes AA. The “PErFecTED technique”: proximal embolization first, then embolize distal for benign prostatic hyperplasia. Cardiovasc Intervent Radiol. 2014;37(6):1602–5.

    Article  PubMed  Google Scholar 

  4. McWilliams JP et al. Society of Interventional Radiology position statement: prostate artery embolization for treatment of benign disease of the prostate. J Vasc Interv Radiol. 2014;25(9):1349–51.

    Article  PubMed  Google Scholar 

  5. Thomas AW et al. The natural history of lower urinary tract dysfunction in men: minimum 10-year urodynamic follow-up of untreated detrusor underactivity. BJU Int. 2005;96(9):1295–300.

    Article  PubMed  Google Scholar 

  6. Aoun F, Marcelis Q, Roumeguere T. Minimally invasive devices for treating lower urinary tract symptoms in benign prostate hyperplasia: technology update. Res Rep Urol. 2015;7:125–36.

    PubMed  PubMed Central  Google Scholar 

  7. Sun F, et al. Prostatic Artery Embolization (PAE) for symptomatic benign prostatic hyperplasia (BPH): Part 2. Insights into the technical rationale. Cardiovasc Interv Radiol, 2015.

  8. DeMeritt JS et al. Relief of Benign Prostatic Hyperplasia-related Bladder Outlet Obstruction after Transarterial Polyvinyl Alcohol Prostate Embolization. J Vasc Interv Radiol. 2000;11(6):767–70.

    Article  CAS  PubMed  Google Scholar 

  9. Jeon GS et al. The effect of transarterial prostate embolization in hormone-induced benign prostatic hyperplasia in dogs: a pilot study. J Vasc Interv Radiol. 2009;20(3):384–90.

    Article  PubMed  Google Scholar 

  10. Carnevale FC et al. Prostatic artery embolization as a primary treatment for benign prostatic hyperplasia: preliminary results in two patients. Cardiovasc Intervent Radiol. 2010;33(2):355–61.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Carnevale FC, Antunes AA. Prostatic artery embolization for enlarged prostates due to benign prostatic hyperplasia. How I do it. Cardiovasc Intervent Radiol. 2013;36(6):1452–63. This study provides extensive technical detail for PAE based on this influential group involved in pioneering PAE as well as vascular anatomy for the prostate. The study focuses on the significance of PAE for a more specific population of patients that are not eligible for TURP, and therefore can benefit from the decreased comorbidities of an interventional procedure compared to open surgery.

    Article  PubMed  Google Scholar 

  12. Bilhim T et al. Middle rectal artery: myth or reality? Retrospective study with CT angiography and digital subtraction angiography. Surg Radiol Anat. 2013;35(6):517–22.

    Article  PubMed  Google Scholar 

  13. Pisco JM et al. Prostatic arterial embolization to treat benign prostatic hyperplasia. J Vasc Interv Radiol. 2011;22(1):11–9. quiz 20.

    Article  PubMed  Google Scholar 

  14. Pisco JM et al. Embolisation of prostatic arteries as treatment of moderate to severe lower urinary symptoms (LUTS) secondary to benign hyperplasia: results of short- and mid-term follow-up. Eur Radiol. 2013;23(9):2561–72.

    Article  PubMed  Google Scholar 

  15. Isaacson AJ, Fischman AM, Burke CT. Technical feasibility of prostatic artery embolization from a transradial approach. AJR Am J Roentgenol. 2016;206(2):442–4.

    Article  PubMed  Google Scholar 

  16. Carnevale FC et al. Midterm follow-up after prostate embolization in two patients with benign prostatic hyperplasia. Cardiovasc Intervent Radiol. 2011;34(6):1330–3.

    Article  PubMed  Google Scholar 

  17. Pisco J et al. Prostatic arterial embolization for benign prostatic hyperplasia: short- and intermediate-term results. Radiology. 2013;266(3):668–77.

    Article  PubMed  Google Scholar 

  18. Bagla S et al. Early results from a United States trial of prostatic artery embolization in the treatment of benign prostatic hyperplasia. J Vasc Interv Radiol. 2014;25(1):47–52. This study provides further technical information related to PAE and data delineating the results for PAE. The study also focuses on benefits and advantages of using cone beam CT.

    Article  PubMed  Google Scholar 

  19. Li Q et al. Prostatic arterial embolization with small sized particles for the treatment of lower urinary tract symptoms due to large benign prostatic hyperplasia: preliminary results. Chin Med J. 2015;128(15):2072–7.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Bilhim T et al. Does polyvinyl alcohol particle size change the outcome of prostatic arterial embolization for benign prostatic hyperplasia? Results from a single-center randomized prospective study. J Vasc Interv Radiol. 2013;24(11):1595–602 e1.

    Article  PubMed  Google Scholar 

  21. Bilhim T et al. Prostatic arterial supply: anatomic and imaging findings relevant for selective arterial embolization. J Vasc Interv Radiol. 2012;23(11):1403–15.

    Article  PubMed  Google Scholar 

  22. Bagla S et al. Utility of cone-beam CT imaging in prostatic artery embolization. J Vasc Interv Radiol. 2013;24(11):1603–7.

    Article  PubMed  Google Scholar 

  23. Russo GI et al. Prostatic arterial embolization vs open prostatectomy: a 1-year matched-pair analysis of functional outcomes and morbidities. Urology. 2015;86(2):343–8.

    Article  PubMed  Google Scholar 

  24. de Assis AM et al. Prostatic artery embolization for treatment of benign prostatic hyperplasia in patients with prostates >90 g: a prospective single-center study. J Vasc Interv Radiol. 2015;26(1):87–93.

    Article  PubMed  Google Scholar 

  25. Gao Y et al. Benign prostatic hyperplasia: prostatic arterial embolization versus transurethral resection of the prostate—a prospective, randomized, and controlled clinical trial. Radiology. 2014;270(3):920–8.

    Article  PubMed  Google Scholar 

  26. Wang MQ et al. Prostatic arterial embolization for the treatment of lower urinary tract symptoms due to large (>80 mL) benign prostatic hyperplasia: results of midterm follow-up from Chinese population. BMC Urol. 2015;15:33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, Division of Interventional Radiology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA

    Amir Noor & Aaron M. Fischman

Authors
  1. Amir Noor
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Aaron M. Fischman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Aaron M. Fischman.

Ethics declarations

Conflict of Interest

Amir Noor declares no potential conflicts of interest.

Aaron Fischman reports grants from Merit Medical and personal fees from Terumo Interventional Systems and Surefire Medical.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on New Imaging Techniques

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Noor, A., Fischman, A.M. Prostate Artery Embolization as a New Treatment for Benign Prostate Hyperplasia: Contemporary Status in 2016. Curr Urol Rep 17, 51 (2016). https://doi.org/10.1007/s11934-016-0608-0

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11934-016-0608-0

Keywords

Search

Navigation